Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 05, 2021
Slayback Pharma has received final approval for its ANDA for Merzee 1 mg/20 mcg from the FDA with a Competitive Generic Therapy Designation.
read more
Amgen announced the FDA has approved RIABNI, a biosimilar to Rituxan.
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more
Tuesday, December 29, 2020
vTv Therapeutics has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971.
read more
Tuesday, December 29, 2020
Quantum Genomics has signed a strategic contract with Delpharm for the manufacture of the next clinical batches of firibastat tablets on an industrial scale and the establishment of production lines for future commercial batches.
read more
Monday, December 28, 2020
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a portfolio of select OTC and prescription pharmaceutical products from Takeda.
read more
Tuesday, December 22, 2020
Nabriva has announced the restructuring of its license agreement with Sinovant for XENLETA in the greater China region.
read more
Monday, December 21, 2020
Torrent is voluntarily recalling one lot of Anagrelide Capsules, USP to the consumer level due to dissolution test failure detected during routine quality testing.
read more
Monday, December 21, 2020
Vectura Group announced an expansion of its capabilities to handle and develop HPAPIs at its facility in Chippenham, U.K.
read more
Monday, December 21, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Faran to develop and commercialize firibastat in Greece.
read more
Friday, December 18, 2020
Ultragenyx Pharmaceutical and Mereo BioPharma Group announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
read more
Friday, December 18, 2020
Vectura has announced its partner Hikma has launched its generic version of GlaxoSmithKline’s Advair Diskus, 100mcg/50mcg and 250mcg/50mcg doses, in the US.
read more
Thursday, December 17, 2020
Aeterna Zentaris has entered into a licensing agreement with Consilient Health for the commercialization in Europe and the United Kingdom of macimorelin.
read more
Friday, December 11, 2020
Viatris has expanded on the restructuring program announced by Mylan earlier this year.
read more
Thursday, December 10, 2020
LIPAC Oncology and Huons announced the achievement of a development milestone in their partnering agreement by finalizing its Clinical Study Report for a Phase 2A marker lesion clinical trial in patients with low-grade highly recurrent NMIBC treated ...
read more